# Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa

> **NCT07169747** · PHASE2 · RECRUITING · sponsor: **Region Skane** · enrollment: 40 (estimated)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT07169747
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-20
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169747, "Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07169747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*